Abstract
Purpose
To study trends in volume and reimbursement for percutaneous kidney biopsy (PKB) by physicians and advanced practice providers (APPs) for Medicare enrollees from 2011–2021.
Methods
Claims from the Medicare Part B Physician/Supplier Procedure Master File (a national Medicare database) for 2011-2021 were extracted using Current Procedural Terminology codes for PKB. Total volumes were compared by provider specialty. Non-facility reimbursement, work Relative Value Unit (RVU) non-facility practice expense RVU, and malpractice RVU were compared.
Results
Between 2011 and 2021, total volume of PKB by physicians and APPs increased from 30,753 to 34,090 (10.9%), with a peak of 37,882 in 2019 prior to the COVID 19 pandemic. Radiology performed the majority of procedures during the study period. Relative share for radiology increased from 67.6% to 81.1% while the relative share for internal medicine/nephrology decreased from 24.3% to 14.3%, accelerating between 2019 and 2020. Volume and relative share for APPs marginally increased (from 0.9% to 1.2%). Non-facility reimbursement decreased from $578.96 in 2010 to $568.76 in 2021 (1.7%), work RVU decreased from 2.63 to 2.38 (9.5%), non-facility practice expense RVU decreased from 14.10 to 13.71 (2.8%), and malpractice RVU decreased from 0.31 to 0.21 (32.3%).
Conclusion
Volume and total share of PKB performed by radiology increased over the study period. Conversely, internal medicine/nephrology performed fewer kidney biopsies. Despite the expanding role for APPs in other image-guided procedures, very few PKBs were performed by APPs throughout the study period. Reimbursement and RVU for PKB declined over the study period.
Similar content being viewed by others
References
Preda, A., Van Dijk, L. C., Van Oostaijen, J. A. & Pattynama, P. M. Complication rate and diagnostic yield of 515 consecutive ultrasound-guided biopsies of renal allografts and native kidneys using a 14-gauge biopsy gun. Eur. Radiol. 13, 527–530 (2003).
Brandenburg, V. M., Frank, R. D. & Riehl, J. Color-coded duplex sonography study of arteriovenous fistulae and pseudoaneurysms complicating percutaneous renal allograft biopsy. Clin. Nephrol. 58, 398–404 (2002).
Agarwal SK, Sethi S, Dinda AK. Basics of kidney biopsy: A nephrologist's perspective. Indian J Nephrol. 2013;23(4):243-52.
Maya ID, Maddela P, Barker J, Allon M. Percutaneous renal biopsy: comparison of blind and real-time ultrasound-guided technique. Semin Dial. 2007;20(4):355-8.
Pongsittisak W, Wutilertcharoenwong N, Ngamvichchukorn T, Kurathong S, Chavanisakun C, Teepprasan T, Prommool S, Srisawat N. The efficacy of blind versus real-time ultrasound-guided percutaneous renal biopsy in developing country. SAGE Open Med. 2019;7:2050312119849770.
ACGME Program Requirements for Graduate Medical Education in Nephrology. Available at: <https://www.acgme.org/globalassets/pfassets/programrequirements/148_nephrology_2020.pdf>. Accessed on 20th March 2023.
Tublin JM, Lindquester WS, Dhangana R, Tublin ME. Growth in Thoracentesis and Paracentesis Performed by Radiology and Advanced Practice Providers: Medicare Volume and Reimbursement Trends From 2012 to 2018. J Am Coll Radiol. 2022;19(5):597-603.
Martinez Garcia RJ, Lindquester W, Dhangana R, Warhadpande S, Amesur N. An expanding role for interventional radiology: Medicare trends in fluoroscopic, endoscopic, and surgical enteric tube placement and maintenance from 2010 to 2018. Clin Imaging. 2021;78:201-205.
Lindquester WS, Dhangana R, Warhadpande S, Amesur NB. Effects of the MAGIC Guidelines on PICC Placement Volume: Advanced Practice Provider and Physician Trends Among Medicare Beneficiaries From 2010 to 2018. AJR Am J Roentgenol. 2021;216(5):1387-1391.
Ozambela M Jr, Wang Y, Leow JJ, Silverman SG, Chung BI, Chang SL. Contemporary trends in percutaneous renal mass biopsy utilization in the United States. Urol Oncol. 2020;38(11):835-843.
Harvey L. Neiman Health Policy Institute Medicare Beneficiary Enrollment Tool. Available at: <https://neimanhpi.org/medicare-beneficiary-enrollment-tool>. Accessed 21st March 2023.
Centers for Medicare & Medicaid Services physician fee schedule look up tool. Available at: <https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/PFSlookup>. Accessed 20th March 2023.
Aggarwal S, Siddiqui WJ, Shahid N, Baynes J, Khattak MW, Ahmed I, Soundararajan S, Ahmed Z. A Comparison between Kidney Allograft Biopsies Performed by Nephrologists and Surgeons Versus Interventional Radiologists. Cureus. 2019;11(12):e6315.
Korbet SM, Whittier WL, Rodby RA. Changing Trends in the Performance of Percutaneous Renal Biopsy from Nephrologist to Interventional Radiologist: A Single-Center Experience. Am J Nephrol. 2018;48(5):326-329.
Yuan CM, Nee R, Little DJ, Narayan R, Childs JM, Prince LK, Raghavan R, Oliver JD 3rd. Nephrology Education Research and Development Consortium (NERDC). Survey of Kidney Biopsy Clinical Practice and Training in the United States. Clin J Am Soc Nephrol. 2018;13(5):718-725.
ACGME Program Requirements for Graduate Medical Education in Interventional Radiology. Available at <https://www.acgme.org/globalassets/PFAssets/ProgramRequirements/415_InterventionalRadiology_2020.pdf>. Accessed 21st March 2023.
Lindquester WS, Hawkins CM, Dhangana R. Reductions in Reimbursement and Relative Value Units for Interventional Radiology Procedures: Trends from 2011 to 2021 Compared with Those for Other Physician Specialties. J Vasc Interv Radiol. 2022;33(8):972-977.
Duszak R Jr, Walls DG, Wang JM, Hemingway J, Hughes DR, Small WC, Bowen MA. Expanding roles of nurse practitioners and physician assistants as providers of nonvascular invasive radiology procedures. J Am Coll Radiol. 2015;12(3):284-9.
United States Renal Data System. 2022 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2022.
National Data: Organ Procurement & Transplant Network. Available at <https://optn.transplant.hrsa.gov/data/view-data-reports/national-data/#>. Accessed 3rd August 2023.
Funding
No funding was obtained for this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest. The authors declare that they had full access to all of the data in this study and the authors take complete responsibility for the integrity of the data and the accuracy of the data analysis.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Lindquester, W.S., Chandra, A., Dhangana, R. et al. Percutaneous kidney biopsy trends in the Medicare population by specialty from 2011 to 2021: implications for nephrology training requirements and radiology referral patterns. Abdom Radiol 48, 3506–3511 (2023). https://doi.org/10.1007/s00261-023-04030-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-023-04030-9